Summary

The Italian Medicines Agency AIFA has updated its updated guidelines for non-prescription medicines, establishing clear criteria that align with the European framework. This significant revision replaces the outdated 1997 circular. The new rules aim to simplify regulatory processes while maintaining high safety standards across international markets.

By streamlining classification and labeling requirements, companies can now focus on execution rather than complex compliance. This strategic shift allows pharmaceutical and life science firms to deliver successful product launch outcomes faster across various regions. The updated framework ensures that these companies have the expertise needed to manage the entire product life cycle effectively. This change enables them to navigate international regulatory hurdles with greater clarity and confidence in the coming year.

Title

Regulatory Pharma Net

Description

Your trusted partner to maximize the potential of your healthcare solutions

Keywords

market, insights, access, event, policy, solutions, affairs, medical, life, companies, expertise, more, convention, europe, medicines, devices, publications

NS Lookup

A 86.107.36.73

Dates

Created 2026-03-09

Updated 2026-04-13

Summarized 2026-04-14